CN111944831A - Ceratopteris chinensis CYP18A1 gene and application thereof - Google Patents
Ceratopteris chinensis CYP18A1 gene and application thereof Download PDFInfo
- Publication number
- CN111944831A CN111944831A CN202010821539.9A CN202010821539A CN111944831A CN 111944831 A CN111944831 A CN 111944831A CN 202010821539 A CN202010821539 A CN 202010821539A CN 111944831 A CN111944831 A CN 111944831A
- Authority
- CN
- China
- Prior art keywords
- cyp18a1
- gene
- fraxinus chinensis
- chinensis
- fraxinus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 89
- 241001148499 Ceratopteris Species 0.000 title description 3
- 241000565359 Fraxinus chinensis Species 0.000 claims abstract description 46
- 238000011161 development Methods 0.000 claims abstract description 23
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 23
- 230000014509 gene expression Effects 0.000 claims abstract description 18
- 230000012010 growth Effects 0.000 claims abstract description 12
- 230000001105 regulatory effect Effects 0.000 claims abstract description 8
- 239000002773 nucleotide Substances 0.000 claims abstract description 5
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 5
- 230000028327 secretion Effects 0.000 claims abstract description 4
- 238000004519 manufacturing process Methods 0.000 claims abstract description 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 2
- 241000238631 Hexapoda Species 0.000 claims description 37
- 239000013598 vector Substances 0.000 claims description 11
- 239000013604 expression vector Substances 0.000 claims description 3
- 241000894006 Bacteria Species 0.000 claims description 2
- 238000009395 breeding Methods 0.000 claims description 2
- 230000001488 breeding effect Effects 0.000 claims description 2
- 230000009261 transgenic effect Effects 0.000 claims description 2
- 238000010353 genetic engineering Methods 0.000 abstract description 2
- 230000001418 larval effect Effects 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 230000002035 prolonged effect Effects 0.000 abstract 1
- 239000007788 liquid Substances 0.000 description 21
- 235000018102 proteins Nutrition 0.000 description 20
- 230000018109 developmental process Effects 0.000 description 18
- 230000001580 bacterial effect Effects 0.000 description 14
- 150000001413 amino acids Chemical group 0.000 description 13
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 12
- 239000013612 plasmid Substances 0.000 description 12
- 229940045860 white wax Drugs 0.000 description 12
- 235000001014 amino acid Nutrition 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- UPEZCKBFRMILAV-JMZLNJERSA-N ecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@H]([C@H](O)CCC(C)(C)O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 UPEZCKBFRMILAV-JMZLNJERSA-N 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 238000012163 sequencing technique Methods 0.000 description 10
- UPEZCKBFRMILAV-JNEQICEOSA-N Ecdysone Natural products O=C1[C@H]2[C@@](C)([C@@H]3C([C@@]4(O)[C@@](C)([C@H]([C@H]([C@@H](O)CCC(O)(C)C)C)CC4)CC3)=C1)C[C@H](O)[C@H](O)C2 UPEZCKBFRMILAV-JNEQICEOSA-N 0.000 description 9
- UPEZCKBFRMILAV-UHFFFAOYSA-N alpha-Ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C(O)CCC(C)(C)O)C)CCC33O)C)C3=CC(=O)C21 UPEZCKBFRMILAV-UHFFFAOYSA-N 0.000 description 9
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 8
- 239000012634 fragment Substances 0.000 description 8
- 239000000499 gel Substances 0.000 description 8
- 239000003446 ligand Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 108020004705 Codon Proteins 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 230000029052 metamorphosis Effects 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 108020004414 DNA Proteins 0.000 description 6
- 239000011324 bead Substances 0.000 description 6
- 239000002299 complementary DNA Substances 0.000 description 6
- 239000001963 growth medium Substances 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 5
- 108091030071 RNAI Proteins 0.000 description 5
- 238000011529 RT qPCR Methods 0.000 description 5
- 229940041514 candida albicans extract Drugs 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000009368 gene silencing by RNA Effects 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000001179 sorption measurement Methods 0.000 description 5
- 239000002699 waste material Substances 0.000 description 5
- 239000012138 yeast extract Substances 0.000 description 5
- ZCFFYALKHPIRKJ-UHFFFAOYSA-N 3-[18-(2-carboxylatoethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethyl-22,23-dihydroporphyrin-21,24-diium-2-yl]propanoate Chemical compound N1C(C=C2C(=C(C)C(=CC=3C(C)=C(CCC(O)=O)C(N=3)=C3)N2)C=C)=C(C)C(C=C)=C1C=C1C(C)=C(CCC(O)=O)C3=N1 ZCFFYALKHPIRKJ-UHFFFAOYSA-N 0.000 description 4
- 241000123410 Ceriporia Species 0.000 description 4
- 229920000858 Cyclodextrin Polymers 0.000 description 4
- 239000001116 FEMA 4028 Substances 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 108700026244 Open Reading Frames Proteins 0.000 description 4
- 238000012408 PCR amplification Methods 0.000 description 4
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 4
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 4
- 229960004853 betadex Drugs 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 229930014550 juvenile hormone Natural products 0.000 description 4
- 239000002949 juvenile hormone Substances 0.000 description 4
- 150000003633 juvenile hormone derivatives Chemical class 0.000 description 4
- 229910001629 magnesium chloride Inorganic materials 0.000 description 4
- 239000000178 monomer Substances 0.000 description 4
- 239000004570 mortar (masonry) Substances 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 239000012137 tryptone Substances 0.000 description 4
- 239000002028 Biomass Substances 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 101150053185 P450 gene Proteins 0.000 description 3
- 239000004098 Tetracycline Substances 0.000 description 3
- 229960000723 ampicillin Drugs 0.000 description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 238000007865 diluting Methods 0.000 description 3
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 3
- 238000001976 enzyme digestion Methods 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 229960002180 tetracycline Drugs 0.000 description 3
- 229930101283 tetracycline Natural products 0.000 description 3
- 235000019364 tetracycline Nutrition 0.000 description 3
- 150000003522 tetracyclines Chemical class 0.000 description 3
- 102100032922 ATP-dependent 6-phosphofructokinase, muscle type Human genes 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000255789 Bombyx mori Species 0.000 description 2
- 241001494246 Daphnia magna Species 0.000 description 2
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 2
- 108010067770 Endopeptidase K Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- XCLCVBYNGXEVDU-WHFBIAKZSA-N Gly-Asn-Ser Chemical compound NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O XCLCVBYNGXEVDU-WHFBIAKZSA-N 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 101000730838 Homo sapiens ATP-dependent 6-phosphofructokinase, muscle type Proteins 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 241000880493 Leptailurus serval Species 0.000 description 2
- NRFGTHFONZYFNY-MGHWNKPDSA-N Leu-Ile-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 NRFGTHFONZYFNY-MGHWNKPDSA-N 0.000 description 2
- 102000003960 Ligases Human genes 0.000 description 2
- 108090000364 Ligases Proteins 0.000 description 2
- 241000830535 Ligustrum lucidum Species 0.000 description 2
- HXOLCSYHGRNXJJ-IHRRRGAJSA-N Pro-Asp-Phe Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O HXOLCSYHGRNXJJ-IHRRRGAJSA-N 0.000 description 2
- 239000013614 RNA sample Substances 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 108010038633 aspartylglutamate Proteins 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 108010015792 glycyllysine Proteins 0.000 description 2
- XMHIUKTWLZUKEX-UHFFFAOYSA-N hexacosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O XMHIUKTWLZUKEX-UHFFFAOYSA-N 0.000 description 2
- 230000013632 homeostatic process Effects 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 108010057821 leucylproline Proteins 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 108010056582 methionylglutamic acid Proteins 0.000 description 2
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 2
- 230000002018 overexpression Effects 0.000 description 2
- 238000006366 phosphorylation reaction Methods 0.000 description 2
- 238000012257 pre-denaturation Methods 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 108010048818 seryl-histidine Proteins 0.000 description 2
- 230000010473 stable expression Effects 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000001890 transfection Methods 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 2
- 235000001892 vitamin D2 Nutrition 0.000 description 2
- 239000011653 vitamin D2 Substances 0.000 description 2
- BIKLGOJMOZLAIG-UHFFFAOYSA-N (3beta,5beta,22R)-3,14,20,22,25,26-hexahydroxycholest-7-en-6-one Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)(O)C(O)CCC(O)(CO)C)CCC33O)C)C3=CC(=O)C21 BIKLGOJMOZLAIG-UHFFFAOYSA-N 0.000 description 1
- -1 100mg/L Amp + Substances 0.000 description 1
- RRCGNPRHZQPOOT-FFBSXHGNSA-N 20,26-dihydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(O)(CO)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 RRCGNPRHZQPOOT-FFBSXHGNSA-N 0.000 description 1
- NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 description 1
- HXWZQRICWSADMH-SEHXZECUSA-N 20-hydroxyecdysone Natural products CC(C)(C)CC[C@@H](O)[C@@](C)(O)[C@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@]4(C)[C@H]3CC[C@]12C HXWZQRICWSADMH-SEHXZECUSA-N 0.000 description 1
- RRCGNPRHZQPOOT-UHFFFAOYSA-N 5,6-dehydro-calotropin Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C)(O)C(O)CCC(O)(CO)C)CCC33O)C)C3=CC(=O)C21 RRCGNPRHZQPOOT-UHFFFAOYSA-N 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- FSBCNCKIQZZASN-GUBZILKMSA-N Ala-Arg-Met Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(O)=O FSBCNCKIQZZASN-GUBZILKMSA-N 0.000 description 1
- TTXMOJWKNRJWQJ-FXQIFTODSA-N Ala-Arg-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CCCN=C(N)N TTXMOJWKNRJWQJ-FXQIFTODSA-N 0.000 description 1
- CWEAKSWWKHGTRJ-BQBZGAKWSA-N Ala-Gly-Met Chemical compound [H]N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCSC)C(O)=O CWEAKSWWKHGTRJ-BQBZGAKWSA-N 0.000 description 1
- HQJKCXHQNUCKMY-GHCJXIJMSA-N Ala-Ile-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](C)N HQJKCXHQNUCKMY-GHCJXIJMSA-N 0.000 description 1
- CJQAEJMHBAOQHA-DLOVCJGASA-N Ala-Phe-Asn Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(=O)N)C(=O)O)N CJQAEJMHBAOQHA-DLOVCJGASA-N 0.000 description 1
- SYIFFFHSXBNPMC-UWJYBYFXSA-N Ala-Ser-Tyr Chemical compound C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N SYIFFFHSXBNPMC-UWJYBYFXSA-N 0.000 description 1
- XSLGWYYNOSUMRM-ZKWXMUAHSA-N Ala-Val-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O XSLGWYYNOSUMRM-ZKWXMUAHSA-N 0.000 description 1
- VWVPYNGMOCSSGK-GUBZILKMSA-N Arg-Arg-Asn Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(O)=O VWVPYNGMOCSSGK-GUBZILKMSA-N 0.000 description 1
- PVSNBTCXCQIXSE-JYJNAYRXSA-N Arg-Arg-Phe Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 PVSNBTCXCQIXSE-JYJNAYRXSA-N 0.000 description 1
- NABSCJGZKWSNHX-RCWTZXSCSA-N Arg-Arg-Thr Chemical compound NC(N)=NCCC[C@@H](C(=O)N[C@@H]([C@H](O)C)C(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N NABSCJGZKWSNHX-RCWTZXSCSA-N 0.000 description 1
- JCAISGGAOQXEHJ-ZPFDUUQYSA-N Arg-Gln-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCN=C(N)N)N JCAISGGAOQXEHJ-ZPFDUUQYSA-N 0.000 description 1
- NMRHDSAOIURTNT-RWMBFGLXSA-N Arg-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N NMRHDSAOIURTNT-RWMBFGLXSA-N 0.000 description 1
- FSNVAJOPUDVQAR-AVGNSLFASA-N Arg-Lys-Arg Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O FSNVAJOPUDVQAR-AVGNSLFASA-N 0.000 description 1
- AOHKLEBWKMKITA-IHRRRGAJSA-N Arg-Phe-Ser Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N AOHKLEBWKMKITA-IHRRRGAJSA-N 0.000 description 1
- XFXZKCRBBOVJKS-BVSLBCMMSA-N Arg-Phe-Trp Chemical compound C([C@H](NC(=O)[C@H](CCCN=C(N)N)N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)C1=CC=CC=C1 XFXZKCRBBOVJKS-BVSLBCMMSA-N 0.000 description 1
- YFHATWYGAAXQCF-JYJNAYRXSA-N Arg-Pro-Phe Chemical compound NC(N)=NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 YFHATWYGAAXQCF-JYJNAYRXSA-N 0.000 description 1
- 235000010576 Artemisia cina Nutrition 0.000 description 1
- 241000238421 Arthropoda Species 0.000 description 1
- ACRYGQFHAQHDSF-ZLUOBGJFSA-N Asn-Asn-Asn Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O ACRYGQFHAQHDSF-ZLUOBGJFSA-N 0.000 description 1
- COUZKSSMBFADSB-AVGNSLFASA-N Asn-Glu-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)N)N COUZKSSMBFADSB-AVGNSLFASA-N 0.000 description 1
- YVXRYLVELQYAEQ-SRVKXCTJSA-N Asn-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N YVXRYLVELQYAEQ-SRVKXCTJSA-N 0.000 description 1
- RCFGLXMZDYNRSC-CIUDSAMLSA-N Asn-Lys-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O RCFGLXMZDYNRSC-CIUDSAMLSA-N 0.000 description 1
- ZYPWIUFLYMQZBS-SRVKXCTJSA-N Asn-Lys-Lys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N ZYPWIUFLYMQZBS-SRVKXCTJSA-N 0.000 description 1
- KYQJHBWHRASMKG-ZLUOBGJFSA-N Asn-Ser-Cys Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(O)=O KYQJHBWHRASMKG-ZLUOBGJFSA-N 0.000 description 1
- QUMKPKWYDVMGNT-NUMRIWBASA-N Asn-Thr-Gln Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O QUMKPKWYDVMGNT-NUMRIWBASA-N 0.000 description 1
- ZUFPUBYQYWCMDB-NUMRIWBASA-N Asn-Thr-Glu Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O ZUFPUBYQYWCMDB-NUMRIWBASA-N 0.000 description 1
- JNCRAQVYJZGIOW-QSFUFRPTSA-N Asn-Val-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JNCRAQVYJZGIOW-QSFUFRPTSA-N 0.000 description 1
- ZCKYZTGLXIEOKS-CIUDSAMLSA-N Asp-Asp-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)N ZCKYZTGLXIEOKS-CIUDSAMLSA-N 0.000 description 1
- AHWRSSLYSGLBGD-CIUDSAMLSA-N Asp-Pro-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O AHWRSSLYSGLBGD-CIUDSAMLSA-N 0.000 description 1
- UAXIKORUDGGIGA-DCAQKATOSA-N Asp-Pro-Lys Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC(=O)O)N)C(=O)N[C@@H](CCCCN)C(=O)O UAXIKORUDGGIGA-DCAQKATOSA-N 0.000 description 1
- 241001490361 Bactrocera minax Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 244000281762 Chenopodium ambrosioides Species 0.000 description 1
- 241001465977 Coccoidea Species 0.000 description 1
- 241000254173 Coleoptera Species 0.000 description 1
- ABLJDBFJPUWQQB-DCAQKATOSA-N Cys-Leu-Arg Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CS)N ABLJDBFJPUWQQB-DCAQKATOSA-N 0.000 description 1
- IZUNQDRIAOLWCN-YUMQZZPRSA-N Cys-Leu-Gly Chemical compound CC(C)C[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CS)N IZUNQDRIAOLWCN-YUMQZZPRSA-N 0.000 description 1
- HEPLXMBVMCXTBP-QWRGUYRKSA-N Cys-Phe-Gly Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(O)=O HEPLXMBVMCXTBP-QWRGUYRKSA-N 0.000 description 1
- GGRDJANMZPGMNS-CIUDSAMLSA-N Cys-Ser-Leu Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O GGRDJANMZPGMNS-CIUDSAMLSA-N 0.000 description 1
- 102000002004 Cytochrome P-450 Enzyme System Human genes 0.000 description 1
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 1
- 102000015214 Cytochrome P450 Family 2 Human genes 0.000 description 1
- 108010064440 Cytochrome P450 Family 2 Proteins 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 102000004594 DNA Polymerase I Human genes 0.000 description 1
- 108010017826 DNA Polymerase I Proteins 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- 208000009701 Embryo Loss Diseases 0.000 description 1
- 241000241611 Ericerus Species 0.000 description 1
- 241000241623 Ericerus pela Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- SHAUZYVSXAMYAZ-JYJNAYRXSA-N Gln-Leu-Phe Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CCC(=O)N)N SHAUZYVSXAMYAZ-JYJNAYRXSA-N 0.000 description 1
- SXGMGNZEHFORAV-IUCAKERBSA-N Gln-Lys-Gly Chemical compound C(CCN)C[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CCC(=O)N)N SXGMGNZEHFORAV-IUCAKERBSA-N 0.000 description 1
- LPIKVBWNNVFHCQ-GUBZILKMSA-N Gln-Ser-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O LPIKVBWNNVFHCQ-GUBZILKMSA-N 0.000 description 1
- FYBSCGZLICNOBA-XQXXSGGOSA-N Glu-Ala-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O FYBSCGZLICNOBA-XQXXSGGOSA-N 0.000 description 1
- ZOXBSICWUDAOHX-GUBZILKMSA-N Glu-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCC(O)=O ZOXBSICWUDAOHX-GUBZILKMSA-N 0.000 description 1
- PXXGVUVQWQGGIG-YUMQZZPRSA-N Glu-Gly-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N PXXGVUVQWQGGIG-YUMQZZPRSA-N 0.000 description 1
- CUXJIASLBRJOFV-LAEOZQHASA-N Glu-Gly-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(O)=O CUXJIASLBRJOFV-LAEOZQHASA-N 0.000 description 1
- ZWQVYZXPYSYPJD-RYUDHWBXSA-N Glu-Gly-Phe Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 ZWQVYZXPYSYPJD-RYUDHWBXSA-N 0.000 description 1
- PJBVXVBTTFZPHJ-GUBZILKMSA-N Glu-Leu-Asp Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)O)N PJBVXVBTTFZPHJ-GUBZILKMSA-N 0.000 description 1
- FBEJIDRSQCGFJI-GUBZILKMSA-N Glu-Leu-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O FBEJIDRSQCGFJI-GUBZILKMSA-N 0.000 description 1
- KJBGAZSLZAQDPV-KKUMJFAQSA-N Glu-Phe-Arg Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CCC(=O)O)N KJBGAZSLZAQDPV-KKUMJFAQSA-N 0.000 description 1
- QNJNPKSWAHPYGI-JYJNAYRXSA-N Glu-Phe-Leu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(O)=O)CC1=CC=CC=C1 QNJNPKSWAHPYGI-JYJNAYRXSA-N 0.000 description 1
- IDEODOAVGCMUQV-GUBZILKMSA-N Glu-Ser-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O IDEODOAVGCMUQV-GUBZILKMSA-N 0.000 description 1
- BGVYNAQWHSTTSP-BYULHYEWSA-N Gly-Asn-Ile Chemical compound [H]NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O BGVYNAQWHSTTSP-BYULHYEWSA-N 0.000 description 1
- BULIVUZUDBHKKZ-WDSKDSINSA-N Gly-Gln-Asn Chemical compound NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O BULIVUZUDBHKKZ-WDSKDSINSA-N 0.000 description 1
- STVHDEHTKFXBJQ-LAEOZQHASA-N Gly-Glu-Ile Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O STVHDEHTKFXBJQ-LAEOZQHASA-N 0.000 description 1
- JSNNHGHYGYMVCK-XVKPBYJWSA-N Gly-Glu-Val Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O JSNNHGHYGYMVCK-XVKPBYJWSA-N 0.000 description 1
- INLIXXRWNUKVCF-JTQLQIEISA-N Gly-Gly-Tyr Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 INLIXXRWNUKVCF-JTQLQIEISA-N 0.000 description 1
- AAHSHTLISQUZJL-QSFUFRPTSA-N Gly-Ile-Ile Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O AAHSHTLISQUZJL-QSFUFRPTSA-N 0.000 description 1
- LLZXNUUIBOALNY-QWRGUYRKSA-N Gly-Leu-Lys Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCCN LLZXNUUIBOALNY-QWRGUYRKSA-N 0.000 description 1
- UUYBFNKHOCJCHT-VHSXEESVSA-N Gly-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN UUYBFNKHOCJCHT-VHSXEESVSA-N 0.000 description 1
- ISSDODCYBOWWIP-GJZGRUSLSA-N Gly-Pro-Trp Chemical compound [H]NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O ISSDODCYBOWWIP-GJZGRUSLSA-N 0.000 description 1
- RYAOJUMWLWUGNW-QMMMGPOBSA-N Gly-Val-Gly Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O RYAOJUMWLWUGNW-QMMMGPOBSA-N 0.000 description 1
- RVKIPWVMZANZLI-UHFFFAOYSA-N H-Lys-Trp-OH Natural products C1=CC=C2C(CC(NC(=O)C(N)CCCCN)C(O)=O)=CNC2=C1 RVKIPWVMZANZLI-UHFFFAOYSA-N 0.000 description 1
- 241000258937 Hemiptera Species 0.000 description 1
- AWASVTXPTOLPPP-MBLNEYKQSA-N His-Ala-Thr Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O AWASVTXPTOLPPP-MBLNEYKQSA-N 0.000 description 1
- OQDLKDUVMTUPPG-AVGNSLFASA-N His-Leu-Glu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O OQDLKDUVMTUPPG-AVGNSLFASA-N 0.000 description 1
- ALPXXNRQBMRCPZ-MEYUZBJRSA-N His-Thr-Phe Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O ALPXXNRQBMRCPZ-MEYUZBJRSA-N 0.000 description 1
- YBDOQKVAGTWZMI-XIRDDKMYSA-N His-Trp-Ser Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC3=CN=CN3)N YBDOQKVAGTWZMI-XIRDDKMYSA-N 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- VSZALHITQINTGC-GHCJXIJMSA-N Ile-Ala-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O)N VSZALHITQINTGC-GHCJXIJMSA-N 0.000 description 1
- HDODQNPMSHDXJT-GHCJXIJMSA-N Ile-Asn-Ser Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O HDODQNPMSHDXJT-GHCJXIJMSA-N 0.000 description 1
- IDAHFEPYTJJZFD-PEFMBERDSA-N Ile-Asp-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N IDAHFEPYTJJZFD-PEFMBERDSA-N 0.000 description 1
- ZDNORQNHCJUVOV-KBIXCLLPSA-N Ile-Gln-Ala Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O ZDNORQNHCJUVOV-KBIXCLLPSA-N 0.000 description 1
- ODPKZZLRDNXTJZ-WHOFXGATSA-N Ile-Gly-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N ODPKZZLRDNXTJZ-WHOFXGATSA-N 0.000 description 1
- UWLHDGMRWXHFFY-HPCHECBXSA-N Ile-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@@H]1C(=O)O)N UWLHDGMRWXHFFY-HPCHECBXSA-N 0.000 description 1
- HUORUFRRJHELPD-MNXVOIDGSA-N Ile-Leu-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N HUORUFRRJHELPD-MNXVOIDGSA-N 0.000 description 1
- GVKKVHNRTUFCCE-BJDJZHNGSA-N Ile-Leu-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O)N GVKKVHNRTUFCCE-BJDJZHNGSA-N 0.000 description 1
- XLXPYSDGMXTTNQ-DKIMLUQUSA-N Ile-Phe-Leu Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(O)=O XLXPYSDGMXTTNQ-DKIMLUQUSA-N 0.000 description 1
- XLXPYSDGMXTTNQ-UHFFFAOYSA-N Ile-Phe-Leu Natural products CCC(C)C(N)C(=O)NC(C(=O)NC(CC(C)C)C(O)=O)CC1=CC=CC=C1 XLXPYSDGMXTTNQ-UHFFFAOYSA-N 0.000 description 1
- NLZVTPYXYXMCIP-XUXIUFHCSA-N Ile-Pro-Lys Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O NLZVTPYXYXMCIP-XUXIUFHCSA-N 0.000 description 1
- VGSPNSSCMOHRRR-BJDJZHNGSA-N Ile-Ser-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)N VGSPNSSCMOHRRR-BJDJZHNGSA-N 0.000 description 1
- HXIDVIFHRYRXLZ-NAKRPEOUSA-N Ile-Ser-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)O)N HXIDVIFHRYRXLZ-NAKRPEOUSA-N 0.000 description 1
- WIYDLTIBHZSPKY-HJWJTTGWSA-N Ile-Val-Phe Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 WIYDLTIBHZSPKY-HJWJTTGWSA-N 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 101710203526 Integrase Proteins 0.000 description 1
- PMGDADKJMCOXHX-UHFFFAOYSA-N L-Arginyl-L-glutamin-acetat Natural products NC(=N)NCCCC(N)C(=O)NC(CCC(N)=O)C(O)=O PMGDADKJMCOXHX-UHFFFAOYSA-N 0.000 description 1
- FADYJNXDPBKVCA-UHFFFAOYSA-N L-Phenylalanyl-L-lysin Natural products NCCCCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FADYJNXDPBKVCA-UHFFFAOYSA-N 0.000 description 1
- FJUKMPUELVROGK-IHRRRGAJSA-N Leu-Arg-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N FJUKMPUELVROGK-IHRRRGAJSA-N 0.000 description 1
- VIWUBXKCYJGNCL-SRVKXCTJSA-N Leu-Asn-His Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 VIWUBXKCYJGNCL-SRVKXCTJSA-N 0.000 description 1
- FIJMQLGQLBLBOL-HJGDQZAQSA-N Leu-Asn-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O FIJMQLGQLBLBOL-HJGDQZAQSA-N 0.000 description 1
- WXHFZJFZWNCDNB-KKUMJFAQSA-N Leu-Asn-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 WXHFZJFZWNCDNB-KKUMJFAQSA-N 0.000 description 1
- ZURHXHNAEJJRNU-CIUDSAMLSA-N Leu-Asp-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O ZURHXHNAEJJRNU-CIUDSAMLSA-N 0.000 description 1
- HGFGEMSVBMCFKK-MNXVOIDGSA-N Leu-Ile-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(O)=O HGFGEMSVBMCFKK-MNXVOIDGSA-N 0.000 description 1
- HVHRPWQEQHIQJF-AVGNSLFASA-N Leu-Lys-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O HVHRPWQEQHIQJF-AVGNSLFASA-N 0.000 description 1
- VCHVSKNMTXWIIP-SRVKXCTJSA-N Leu-Lys-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O VCHVSKNMTXWIIP-SRVKXCTJSA-N 0.000 description 1
- BJWKOATWNQJPSK-SRVKXCTJSA-N Leu-Met-Glu Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N BJWKOATWNQJPSK-SRVKXCTJSA-N 0.000 description 1
- HDHQQEDVWQGBEE-DCAQKATOSA-N Leu-Met-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(O)=O HDHQQEDVWQGBEE-DCAQKATOSA-N 0.000 description 1
- YWKNKRAKOCLOLH-OEAJRASXSA-N Leu-Phe-Thr Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)O)C(O)=O)CC1=CC=CC=C1 YWKNKRAKOCLOLH-OEAJRASXSA-N 0.000 description 1
- YUTNOGOMBNYPFH-XUXIUFHCSA-N Leu-Pro-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(O)=O YUTNOGOMBNYPFH-XUXIUFHCSA-N 0.000 description 1
- PWPBLZXWFXJFHE-RHYQMDGZSA-N Leu-Pro-Thr Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O PWPBLZXWFXJFHE-RHYQMDGZSA-N 0.000 description 1
- UCXQIIIFOOGYEM-ULQDDVLXSA-N Leu-Pro-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 UCXQIIIFOOGYEM-ULQDDVLXSA-N 0.000 description 1
- AKVBOOKXVAMKSS-GUBZILKMSA-N Leu-Ser-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(O)=O AKVBOOKXVAMKSS-GUBZILKMSA-N 0.000 description 1
- KLSUAWUZBMAZCL-RHYQMDGZSA-N Leu-Thr-Pro Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(O)=O KLSUAWUZBMAZCL-RHYQMDGZSA-N 0.000 description 1
- WGAZVKFCPHXZLO-SZMVWBNQSA-N Leu-Trp-Glu Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N WGAZVKFCPHXZLO-SZMVWBNQSA-N 0.000 description 1
- RDFIVFHPOSOXMW-ACRUOGEOSA-N Leu-Tyr-Phe Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O RDFIVFHPOSOXMW-ACRUOGEOSA-N 0.000 description 1
- IBQMEXQYZMVIFU-SRVKXCTJSA-N Lys-Asp-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)N IBQMEXQYZMVIFU-SRVKXCTJSA-N 0.000 description 1
- GRADYHMSAUIKPS-DCAQKATOSA-N Lys-Glu-Gln Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O GRADYHMSAUIKPS-DCAQKATOSA-N 0.000 description 1
- PBIPLDMFHAICIP-DCAQKATOSA-N Lys-Glu-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O PBIPLDMFHAICIP-DCAQKATOSA-N 0.000 description 1
- PBLLTSKBTAHDNA-KBPBESRZSA-N Lys-Gly-Phe Chemical compound [H]N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O PBLLTSKBTAHDNA-KBPBESRZSA-N 0.000 description 1
- OJDFAABAHBPVTH-MNXVOIDGSA-N Lys-Ile-Gln Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(O)=O OJDFAABAHBPVTH-MNXVOIDGSA-N 0.000 description 1
- QBEPTBMRQALPEV-MNXVOIDGSA-N Lys-Ile-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCCCN QBEPTBMRQALPEV-MNXVOIDGSA-N 0.000 description 1
- JYXBNQOKPRQNQS-YTFOTSKYSA-N Lys-Ile-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JYXBNQOKPRQNQS-YTFOTSKYSA-N 0.000 description 1
- KEPWSUPUFAPBRF-DKIMLUQUSA-N Lys-Ile-Phe Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O KEPWSUPUFAPBRF-DKIMLUQUSA-N 0.000 description 1
- AIRZWUMAHCDDHR-KKUMJFAQSA-N Lys-Leu-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O AIRZWUMAHCDDHR-KKUMJFAQSA-N 0.000 description 1
- MSSJJDVQTFTLIF-KBPBESRZSA-N Lys-Phe-Gly Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(O)=O MSSJJDVQTFTLIF-KBPBESRZSA-N 0.000 description 1
- YTJFXEDRUOQGSP-DCAQKATOSA-N Lys-Pro-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O YTJFXEDRUOQGSP-DCAQKATOSA-N 0.000 description 1
- DIBZLYZXTSVGLN-CIUDSAMLSA-N Lys-Ser-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O DIBZLYZXTSVGLN-CIUDSAMLSA-N 0.000 description 1
- IEVXCWPVBYCJRZ-IXOXFDKPSA-N Lys-Thr-His Chemical compound NCCCC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 IEVXCWPVBYCJRZ-IXOXFDKPSA-N 0.000 description 1
- RQILLQOQXLZTCK-KBPBESRZSA-N Lys-Tyr-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(O)=O RQILLQOQXLZTCK-KBPBESRZSA-N 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- YYEIFXZOBZVDPH-DCAQKATOSA-N Met-Lys-Asp Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O YYEIFXZOBZVDPH-DCAQKATOSA-N 0.000 description 1
- HAQLBBVZAGMESV-IHRRRGAJSA-N Met-Lys-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O HAQLBBVZAGMESV-IHRRRGAJSA-N 0.000 description 1
- XIGAHPDZLAYQOS-SRVKXCTJSA-N Met-Pro-Pro Chemical compound CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 XIGAHPDZLAYQOS-SRVKXCTJSA-N 0.000 description 1
- VEKRTVRZDMUOQN-AVGNSLFASA-N Met-Val-His Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CNC=N1 VEKRTVRZDMUOQN-AVGNSLFASA-N 0.000 description 1
- IQJMEDDVOGMTKT-SRVKXCTJSA-N Met-Val-Val Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(O)=O IQJMEDDVOGMTKT-SRVKXCTJSA-N 0.000 description 1
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 1
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 1
- 108010087066 N2-tryptophyllysine Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 241000819999 Nymphes Species 0.000 description 1
- 241000269979 Paralichthys olivaceus Species 0.000 description 1
- HCTXJGRYAACKOB-SRVKXCTJSA-N Phe-Asn-Asp Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N HCTXJGRYAACKOB-SRVKXCTJSA-N 0.000 description 1
- ZENDEDYRYVHBEG-SRVKXCTJSA-N Phe-Asp-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 ZENDEDYRYVHBEG-SRVKXCTJSA-N 0.000 description 1
- CUMXHKAOHNWRFQ-BZSNNMDCSA-N Phe-Asp-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 CUMXHKAOHNWRFQ-BZSNNMDCSA-N 0.000 description 1
- LLGTYVHITPVGKR-RYUDHWBXSA-N Phe-Gln-Gly Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O LLGTYVHITPVGKR-RYUDHWBXSA-N 0.000 description 1
- KYYMILWEGJYPQZ-IHRRRGAJSA-N Phe-Glu-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 KYYMILWEGJYPQZ-IHRRRGAJSA-N 0.000 description 1
- HGNGAMWHGGANAU-WHOFXGATSA-N Phe-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=CC=C1 HGNGAMWHGGANAU-WHOFXGATSA-N 0.000 description 1
- ONORAGIFHNAADN-LLLHUVSDSA-N Phe-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)N ONORAGIFHNAADN-LLLHUVSDSA-N 0.000 description 1
- ROOQMPCUFLDOSB-FHWLQOOXSA-N Phe-Phe-Gln Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCC(N)=O)C(O)=O)C1=CC=CC=C1 ROOQMPCUFLDOSB-FHWLQOOXSA-N 0.000 description 1
- GPLWGAYGROGDEN-BZSNNMDCSA-N Phe-Phe-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O GPLWGAYGROGDEN-BZSNNMDCSA-N 0.000 description 1
- CKJACGQPCPMWIT-UFYCRDLUSA-N Phe-Pro-Phe Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CKJACGQPCPMWIT-UFYCRDLUSA-N 0.000 description 1
- ODGNUUUDJONJSC-UFYCRDLUSA-N Phe-Pro-Tyr Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)N)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O ODGNUUUDJONJSC-UFYCRDLUSA-N 0.000 description 1
- BPCLGWHVPVTTFM-QWRGUYRKSA-N Phe-Ser-Gly Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)NCC(O)=O BPCLGWHVPVTTFM-QWRGUYRKSA-N 0.000 description 1
- KPDRZQUWJKTMBP-DCAQKATOSA-N Pro-Asp-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1 KPDRZQUWJKTMBP-DCAQKATOSA-N 0.000 description 1
- NMELOOXSGDRBRU-YUMQZZPRSA-N Pro-Glu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1 NMELOOXSGDRBRU-YUMQZZPRSA-N 0.000 description 1
- NXEYSLRNNPWCRN-SRVKXCTJSA-N Pro-Glu-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O NXEYSLRNNPWCRN-SRVKXCTJSA-N 0.000 description 1
- BCNRNJWSRFDPTQ-HJWJTTGWSA-N Pro-Ile-Phe Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O BCNRNJWSRFDPTQ-HJWJTTGWSA-N 0.000 description 1
- GOMUXSCOIWIJFP-GUBZILKMSA-N Pro-Ser-Arg Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O GOMUXSCOIWIJFP-GUBZILKMSA-N 0.000 description 1
- 241000382353 Pupa Species 0.000 description 1
- 238000001190 Q-PCR Methods 0.000 description 1
- 238000010802 RNA extraction kit Methods 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- KYKKKSWGEPFUMR-NAKRPEOUSA-N Ser-Arg-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O KYKKKSWGEPFUMR-NAKRPEOUSA-N 0.000 description 1
- TYYBJUYSTWJHGO-ZKWXMUAHSA-N Ser-Asn-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O TYYBJUYSTWJHGO-ZKWXMUAHSA-N 0.000 description 1
- YPUSXTWURJANKF-KBIXCLLPSA-N Ser-Gln-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O YPUSXTWURJANKF-KBIXCLLPSA-N 0.000 description 1
- RIAKPZVSNBBNRE-BJDJZHNGSA-N Ser-Ile-Leu Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O RIAKPZVSNBBNRE-BJDJZHNGSA-N 0.000 description 1
- IXZHZUGGKLRHJD-DCAQKATOSA-N Ser-Leu-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O IXZHZUGGKLRHJD-DCAQKATOSA-N 0.000 description 1
- PJIQEIFXZPCWOJ-FXQIFTODSA-N Ser-Pro-Asp Chemical compound [H]N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O PJIQEIFXZPCWOJ-FXQIFTODSA-N 0.000 description 1
- PLQWGQUNUPMNOD-KKUMJFAQSA-N Ser-Tyr-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O PLQWGQUNUPMNOD-KKUMJFAQSA-N 0.000 description 1
- PCMZJFMUYWIERL-ZKWXMUAHSA-N Ser-Val-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O PCMZJFMUYWIERL-ZKWXMUAHSA-N 0.000 description 1
- UYTYTDMCDBPDSC-URLPEUOOSA-N Thr-Ile-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N UYTYTDMCDBPDSC-URLPEUOOSA-N 0.000 description 1
- DCRHJDRLCFMEBI-RHYQMDGZSA-N Thr-Lys-Met Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(O)=O DCRHJDRLCFMEBI-RHYQMDGZSA-N 0.000 description 1
- BBPCSGKKPJUYRB-UVOCVTCTSA-N Thr-Thr-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O BBPCSGKKPJUYRB-UVOCVTCTSA-N 0.000 description 1
- CSNBWOJOEOPYIJ-UVOCVTCTSA-N Thr-Thr-Lys Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(O)=O CSNBWOJOEOPYIJ-UVOCVTCTSA-N 0.000 description 1
- ILDJYIDXESUBOE-HSCHXYMDSA-N Trp-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N ILDJYIDXESUBOE-HSCHXYMDSA-N 0.000 description 1
- AKFLVKKWVZMFOT-IHRRRGAJSA-N Tyr-Arg-Asn Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(O)=O AKFLVKKWVZMFOT-IHRRRGAJSA-N 0.000 description 1
- GFZQWWDXJVGEMW-ULQDDVLXSA-N Tyr-Arg-Lys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)O)N)O GFZQWWDXJVGEMW-ULQDDVLXSA-N 0.000 description 1
- GULIUBBXCYPDJU-CQDKDKBSSA-N Tyr-Leu-Ala Chemical compound [O-]C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]([NH3+])CC1=CC=C(O)C=C1 GULIUBBXCYPDJU-CQDKDKBSSA-N 0.000 description 1
- QGFPYRPIUXBYGR-YDHLFZDLSA-N Val-Asn-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N QGFPYRPIUXBYGR-YDHLFZDLSA-N 0.000 description 1
- LAYSXAOGWHKNED-XPUUQOCRSA-N Val-Gly-Ser Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O LAYSXAOGWHKNED-XPUUQOCRSA-N 0.000 description 1
- OPGWZDIYEYJVRX-AVGNSLFASA-N Val-His-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N OPGWZDIYEYJVRX-AVGNSLFASA-N 0.000 description 1
- HQYVQDRYODWONX-DCAQKATOSA-N Val-His-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CO)C(=O)O)N HQYVQDRYODWONX-DCAQKATOSA-N 0.000 description 1
- OTJMMKPMLUNTQT-AVGNSLFASA-N Val-Leu-Arg Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](C(C)C)N OTJMMKPMLUNTQT-AVGNSLFASA-N 0.000 description 1
- ZLNYBMWGPOKSLW-LSJOCFKGSA-N Val-Val-Asp Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O ZLNYBMWGPOKSLW-LSJOCFKGSA-N 0.000 description 1
- AOILQMZPNLUXCM-AVGNSLFASA-N Val-Val-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCCN AOILQMZPNLUXCM-AVGNSLFASA-N 0.000 description 1
- JSOXWWFKRJKTMT-WOPDTQHZSA-N Val-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N JSOXWWFKRJKTMT-WOPDTQHZSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 108010081404 acein-2 Proteins 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 108010005233 alanylglutamic acid Proteins 0.000 description 1
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 1
- 108010008355 arginyl-glutamine Proteins 0.000 description 1
- 108010060035 arginylproline Proteins 0.000 description 1
- 108010093581 aspartyl-proline Proteins 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- NKDFYOWSKOHCCO-UHFFFAOYSA-N beta-ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C)(O)C(O)CCC(C)(O)C)CCC33O)C)C3=CC(=O)C21 NKDFYOWSKOHCCO-UHFFFAOYSA-N 0.000 description 1
- 239000003012 bilayer membrane Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000004252 chorionic villi Anatomy 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000005058 diapause Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 108010054813 diprotin B Proteins 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 238000010195 expression analysis Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 102000034356 gene-regulatory proteins Human genes 0.000 description 1
- 108091006104 gene-regulatory proteins Proteins 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 108010078144 glutaminyl-glycine Proteins 0.000 description 1
- 108010085059 glutamyl-arginyl-proline Proteins 0.000 description 1
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 1
- 108010079547 glutamylmethionine Proteins 0.000 description 1
- 108010010147 glycylglutamine Proteins 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 210000000087 hemolymph Anatomy 0.000 description 1
- 230000010196 hermaphroditism Effects 0.000 description 1
- 108010092114 histidylphenylalanine Proteins 0.000 description 1
- 108010018006 histidylserine Proteins 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- 108010044311 leucyl-glycyl-glycine Proteins 0.000 description 1
- 108010044056 leucyl-phenylalanine Proteins 0.000 description 1
- 238000013332 literature search Methods 0.000 description 1
- 108010009298 lysylglutamic acid Proteins 0.000 description 1
- 108010064235 lysylglycine Proteins 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 150000007523 nucleic acids Chemical group 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000009437 off-target effect Effects 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 108010070409 phenylalanyl-glycyl-glycine Proteins 0.000 description 1
- 108010051242 phenylalanylserine Proteins 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108010087846 prolyl-prolyl-glycine Proteins 0.000 description 1
- 108010090894 prolylleucine Proteins 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000002096 quantum dot Substances 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000011222 transcriptome analysis Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 108010038745 tryptophylglycine Proteins 0.000 description 1
- 108010035534 tyrosyl-leucyl-alanine Proteins 0.000 description 1
- 108010051110 tyrosyl-lysine Proteins 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 230000006614 vitellogenesis Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000022814 xenobiotic metabolic process Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
- C12N9/0077—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with a reduced iron-sulfur protein as one donor (1.14.15)
- C12N9/0081—Cholesterol monooxygenase (cytochrome P 450scc)(1.14.15.6)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/033—Rearing or breeding invertebrates; New breeds of invertebrates
- A01K67/0333—Genetically modified invertebrates, e.g. transgenic, polyploid
- A01K67/0335—Genetically modified worms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
- C12Y114/15—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen (1.14.15)
- C12Y114/15006—Cholesterol monooxygenase (side-chain-cleaving) (1.14.15.6), i.e. cytochrome P450scc
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/70—Invertebrates
- A01K2227/706—Insects, e.g. Drosophila melanogaster, medfly
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Environmental Sciences (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention relates to a fraxinus chinensis CYP18A1 gene and application thereof, belonging to the technical field of genetic engineering. The nucleotide sequence of the fraxinus chinensis CYP18A1 gene is shown in SEQ ID NO.1, and the amino acid sequence of the encoded protein is shown in SEQ ID NO. 2. The fraxinus chinensis CYP18A1 gene has obvious influence on the growth and development of larval stages of fraxinus chinensis, CYP18A1 expression is interfered, expression quantity is reduced, the development of fraxinus chinensis is slow, body length, body width and body surface area are all obviously smaller than those of a control group, and the results prove that the growth and development speed of fraxinus chinensis can be regulated and controlled through the gene or derivatives thereof, the wax secretion time of fraxinus chinensis can be prolonged, provenance is excellent, fine variety of fraxinus chinensis is cultivated, the yield of fraxinus chinensis is improved, dependence on climate and environment is eliminated in production of fraxinus chinensis, and the fraxinus chinensis gene has important significance for excavating new biological resources and promoting development of fraxinus chinensis industry.
Description
Technical Field
The invention belongs to the technical field of genetic engineering, particularly relates to a fraxinus chinensis CYP18A1 gene and application thereof, and particularly relates to regulation and control of the fraxinus chinensis ecdysone hydrolase CYP18A1 gene on development of fraxinus chinensis and application thereof.
Background
Ericerus pela channels is an important resource insect, belongs to the genus Ericerus of the superfamily Hemiptera (coccoidea) scale, and is distributed in the monsoon regions of northern subtropics, middle subtropics, and temperate zones (Zhang Changhai, 1991). The second-instar male nymphs of the wax insects secrete a large amount of biomass wax, the main components of the biomass wax are hexacosanoic acid (C25H51COOC26H53), the biomass wax has ecological values of protecting the growth and development of the wax insects and nutritional health-care and economic values, and is widely applied to the fields of printing, machinery, medicines, foods, cosmetics and the like (Xiaoming, 2011). The fraxinus chinensis has unique hermaphrodite development phenomena, namely, the female is in incomplete metamorphosis development, the male is in complete metamorphosis development, wherein the fraxinus chinensis nymphs of the first age migrate to leaves to feed as fixed leaves in the initial stage, and the fraxinus chinensis nymphs of the second age migrate to trunks as fixed stems in the initial stage. The life cycle of the female is as long as one year, and the main life process of the female is adult pregnant eggs; the life cycle of the male is five months, a large amount of white wax is generated to cover the larva bodies during the period of fixing the second-instar nymphs, the larva bodies under the wax layer complete the metamorphosis process of the second-instar male nymphs, prepupa, pupa and male adults, and the larva bodies are dead after mating with female worms in the male adult period of 10-15 days. In the late stage of the second-instar male nymphs of the fraxinus chinensis, the difference between the titer of Juvenile Hormone (JH) and the titer of ecdysone (20E) is large, the ecdysone effect is dominant, and the male nymphs are regulated and controlled to enter a complete metamorphosis development stage; the difference between the JH titer and the 20E titer of the second-instar female nymphs is small, juvenile hormone is dominant, and the female nymphs are regulated to enter an incomplete metamorphosis development stage.
Inactivation of ecdysone (20E) is essential for normal development, cytochrome P450 enzymes regulate insect ecdysone homeostasis, and CYP18a1 is a key enzyme in this process. CYP18a1 is a 26-hydroxylase of the CYP2 family, plays an important role in the catabolism of 20-hydroxyecdysone, is capable of converting 20E to 20, 26-dihydroxyecdysone while participating in xenobiotic metabolic processes, is conserved among most arthropods, and CYP18a1 has been shown to be induced by ecdysoid steroids, playing an important role in the preparation of metamorphosis and ecdysis. In drosophila, the knock-out of CYP18a1 results in the lethality of pupal, possibly as a result of impaired ecdysone degradation, and overexpression of CYP18a1 in PG results in nymph development arrest, indicating that CYP18a1 can inactivate all ecdysone and that a reduction in CYP18a1 transcriptional expression may impair the developmental stages of drosophila. In silkworms, CYP18A1 not only has an expression profile of time and tissue specificity, but also has an expression pattern closely related to the peak of ecdysone accumulation in haemolymph of silkworms, which shows that homologous CYP18A1 of insects is closely related to ecdysone homeostasis, the over-expression of CYP18A1 leads to the stunted development of terminal-age larvae, and the 20E titer in the insects over-expressing CYP18A1 is lower than that of a control group. CYP18a1 gene expression levels were significantly elevated prior to the transition from vitellogenesis to chorionic villus suggesting that it may lead to a reduction in the titer of this transition 20E. In Daphnia magna (Daphnia magna), the knockout of CYP18a1 gene leads to early embryo death before the first molting, possibly regulating the drop in molting steroid titer before molting and ovulation, and in bactrocera minax, the expression of CYP18a1 is relatively low throughout diapause.
Through the literature search, the same public reports as the invention are not found.
Disclosure of Invention
The invention aims to solve the defects of the prior art and provides a gene related to the growth and development of the fraxinus chinensis so as to regulate and control the development time of the fraxinus chinensis and increase the second-instar larva period of the fraxinus chinensis.
In order to achieve the purpose, the technical scheme adopted by the invention is as follows:
the first aspect of the invention provides a wax insect CYP18A1 gene, and the nucleotide sequence of the wax insect CYP18A1 gene is shown in SEQ ID NO. 1.
The second aspect of the invention provides a coded protein of the wax insect CYP18A1 gene, and the amino acid sequence of the coded protein is shown in SEQ ID NO. 2.
The third aspect of the invention provides an expression vector, an expression cassette, a transgenic cell line or a recombinant bacterium containing the fraxinus chinensis CYP18A1 gene.
The fourth aspect of the invention provides a recombinant vector containing a target gene in the fraxinus chinensis CYP18A1 gene, wherein the nucleotide sequence of the target gene is shown as SEQ ID NO. 3.
The fifth aspect of the invention provides application of the wax insect CYP18A1 gene in regulating the growth and development speed of the wax insect.
The sixth aspect of the invention provides application of the fraxinus chinensis CYP18A1 gene in prolonging the wax secretion time of fraxinus chinensis.
The seventh aspect of the invention provides an application of the fraxinus chinensis CYP18A1 gene in breeding of improved fraxinus chinensis seeds.
The eighth aspect of the invention provides application of the fraxinus chinensis CYP18A1 gene in increasing yield of fraxinus chinensis.
The fraxinus chinensis CYP18A1 gene is obtained through transcriptome, the nucleic acid sequence of the gene is shown as SEQ ID NO.1, the length of the sequence is 16997 bp, the Codon Adaptation Index (CAI) is 0.698, the number of effective codons (ENC) is 52.698, and the GC content: 45.27%, GC3s content: 57.65%, having 1 Open Reading Frame (ORF), length 1, 608bp, stop codon TAA.
The amino acid sequence of the protein coded by the wax insect CYP18A1 gene is shown in SEQ ID NO.2 according to the degeneracy and the preference of codons. The protein contains 535 amino acids, the highest content of the 535 amino acids is Leu (L) (58, accounting for 10.8 percent), and the protein does not contain two amino acids of Pyl (O) and Sec (U); the instability factor was 45.84, greater than 40. The target gene segment of the wax insect CYP18A1 for RNAi interference is shown in SEQ ID NO. 3. Exogenous vector plasmid L4440-CYP18A1 is constructed, DH5 alpha is transformed into recombinant vector plasmid recombinant plasmid target genes, a large amount of double-stranded RNA (dsRNA) of the target genes is expressed and accumulated in HT115, and the dsRNA of the target genes is sprayed on the wax insect to influence the growth and development of the wax insect.
Compared with the prior art, the invention has the beneficial effects that:
the white wax worm CYP18A1 gene has obvious influence on the growth and development of the larval stage of the white wax worm, CYP18A1 expression is interfered, the expression quantity is reduced, the white wax worm develops slowly, the body surface projection area is obviously smaller than a negative Control group CK (a natural group which is not treated) and a positive Control group Control (a group treated by HT 115/L4440), and the gene or a derivative thereof can be used for regulating the growth and development speed of the white wax worm, prolonging the wax secretion time of the white wax worm, screening excellent seed sources, cultivating fine white wax worm seeds, improving the yield of the white wax worm, enabling the white wax production to get rid of dependence on climate and environment, and having important significance on excavating new biological resources and promoting the development of the white wax industry.
Drawings
FIG. 1 is a hydropathic assay of the wax insect CYP18A1 protein; wherein, the maximum hydrophobic value of the amino acid at the 23 th position is 2.844, the minimum hydrophilic value of-2.744 appears between the amino acids at the 152 th position, the average hydrophobic property is-0.204, and the protein is amphiprotic hydrophilic protein;
FIG. 2 is an analysis of the transmembrane domain of the Ceratoptera chinensis CYP18A1 protein; note: CYP18a1 protein is a transmembrane bilayer membrane protein;
FIG. 3 is a functional locus of the Ceratoptera chinensis CYP18A1 protein, endoplasmic reticulum;
FIG. 4 is an analysis of Ceratoptera chinensis CYP18A1 protein belonging to the P450 superfamily family; the CYP18A1 protein contains a plurality of conserved structural domains, mainly belongs to the p450 superfamily family, the structural domain is positioned at the 40 th to 506 th amino acids, the region contains the most conserved haemoglobin binding domain, and the haemoglobin binding domain contains an absolutely conserved cysteine residue and is the fifth coordination ligand of the iron haemoglobin. (ii) a
FIG. 5 is a tertiary structure analysis of the protein of Ceratoptera chinensis CYP18A 1; the tertiary structure of CYP18A1 is a monomer (monomer) formed by 253 alpha-helices, 26 Beta-turns, 55 extended chains and 201 random coils, and contains 1 BCD (Beta-Cyclodextrin) ligand, 1 HEM (PROTOPORPH YRIN IX CONTAINING FE) ligand, 1D 2V ((3S, 5Z, 7E, 22E) -9, 10-secoe rgosta-5, 7, 10, 22-tetraen-3-ol) ligand, and shorter extended peptide segments at the C and N terminals;
FIG. 6 is a PFKM value analysis of Ceratoptera chinensis CYP18A1 at 6 different developmental stages;
FIG. 7 shows the PCR amplification result (318bp) of the wax insect CYP18A1 target gene;
FIG. 8 shows the stable expression of wax insect CYP18A1 target gene reconstruction vector L4440-CYP18A1 in competent cell DH5 alpha, the left picture shows the single bacterial colony clone culture of DH5 alpha (L4440-CYP18A1), and the right picture shows the PCR result (318bp) of DH5 alpha (L4440-CYP18A1) bacterial liquid;
FIG. 9 shows the sequencing result of the recombinant plasmid CYP18A1/L4440-HT115, 1. Cluster-representing the transcriptome sequence, and 2.f-f representing the sequencing result sequence of the company
FIG. 10 shows the stable expression of wax insect CYP18A1 target gene recombinant vector L4440-CYP18A1 in HT115, the left picture shows the single colony clone culture of HT115(L4440-CYP18A1), and the right picture shows the PCR result (318bp) of HT115(L4440-CYP18A1) bacterial liquid;
FIG. 11 shows the in vivo expression abundance of the target gene CYP18A1 after the wax insect body is subjected to RNAi of the target gene CYP18A1, CYP18A1(30mg/ml) is an experimental group, and Control is a positive Control group (inconsistent with the marker in the figure);
FIG. 12 shows the change of growth state of Ceriporia chinensis in 30 days after the RNAi of the Ceriporia chinensis CYP18A1 target gene, CK is a negative control group (natural group), time is the sampling date, 6.02(6 months 2 days), 6.12(6 months 12 days), 6.22(6 months 22 days), and 7.02(7 months 2 days);
FIG. 13 is a graph showing the change in the growth rate of Ceriporia alba after 40 days from the RNAi of the Ceriporia alba CYP18A1 target gene; CYP18A1 is an experimental group, Control is a positive Control group, and CK is a natural group;
FIG. 14 is a schematic diagram of library construction.
Detailed Description
The present invention will be described in further detail with reference to examples.
It will be appreciated by those skilled in the art that the following examples are illustrative of the invention only and should not be taken as limiting the scope of the invention. The examples do not specify particular techniques or conditions, and are performed according to the techniques or conditions described in the literature in the art or according to the product specifications. The materials or equipment used are not indicated by manufacturers, and all are conventional products available by purchase.
First, the obtainment of Ceratopteris albidus CYP18A1 Gene
1. Material
The wax insect is sourced from Sichuan Showa (northern latitude: 27.33, east longitude: 103.72, altitude 1685m), the wax insect sample is collected in resource insect institute of Chinese forestry science research institute (northern latitude 25 degrees 3 '20', east longitude 102 degrees 45 '16', altitude 1950m), the parasitic tree is Ligustrum lucidum (Ligustrum lucidum), samples of six periods of FF, SF, EA, LA, FM and SM are collected in total, three groups of biological repetitions of each sample are collected, and the samples are frozen and stored at-80 ℃.
2. Extraction of fraxinus chinensis total RNA:
the total RNA of the white wax worm body is extracted by using an RNA extraction kit (EZ-10Tatal RNA Minin-presps kit) (Shanghai, Biotechnology engineering (Shanghai), Inc.), and the experimental steps are as follows;
(1) taking a clean small mortar, igniting with alcohol, heating and sterilizing to remove RNase;
(2) cooling the mortar by using liquid nitrogen until water vapor is condensed around the mortar;
(3) taking 20mg of fresh fraxinus chinensis insect bodies, adding into a mortar, and quickly grinding into powder;
(4) the powdery fraxinus chinensis tissues are quickly transferred into a 1.5ml RNase-free PE tube, 300 mul of RLT buffer is added, the mixture is slightly shaken and shaken evenly, and the mixture is kept stand for 5 minutes at room temperature;
(5) adding 10 μ l PK (protease K) and 590 μ l RNase-free water, mixing, and placing in 55 deg.C water bath for 10 min;
(6) centrifuging at 4 deg.C for 3 min at 12000g/min, collecting supernatant, adding into 1.5ml RNase-free PE tube, and removing precipitate;
(7) 1/2 supernatant (450-;
(8) 1/2 adding the above mixture into RNase-free adsorption column, centrifuging at 12000g/min for 2 min, and discarding the waste liquid; adding the rest 1/2 mixture into the same centrifugal column, and repeating the above steps;
(9) adding 350 mul DW (DW washing solvent), centrifuging at 12000g/min for 1min at room temperature, and discarding the waste liquid;
(10) adding 500 mul DW, centrifuging at 12000g/min for 1min, discarding the waste liquid, and repeating once;
(11) idling the centrifugal machine 12000g/min at room temperature, taking out the adsorption column beside the alcohol lamp, placing the adsorption column in a 1.5ml RNase-free PE tube, and standing for 2 minutes at room temperature;
(12) adding 50 mul of RNase-free water, and standing for 2 minutes at room temperature; centrifuge at 12000g/min for 1 min.
3. Sequencing transcriptome data: sequencing by Seno Nuo grass genesis Limited liability company, comprising the following steps (1) white wax insect Total RNA sample detection
The detection of RNA samples by a Nordheim source mainly comprises 4 methods:
A. analyzing the degradation degree of RNA and whether pollution exists by agarose gel electrophoresis;
purity of the Nanodrop detection RNA (OD260/280 ratio);
c, accurately quantifying the RNA concentration by the qubit;
agilent 2100 accurately detects RNA integrity;
(2) wax insect cDNA library construction and library inspection
After the sample is qualified, the magnetic beads with oligo (dT) are used for enriching the eukaryotic mRNA. Then fragmentation buffer is added to break mRNA into short fragments, mRNA is used as a template, hexabasic random primers (random hexamers) are used for synthesizing single-strand cDNA, buffer solution, dNTPs, DNA polymerase I and RNase H are added to synthesize double-strand cDNA, and AMPure XP beads are used for purifying double-strand cDNA. The purified double-stranded cDNA is subjected to end repair, A tail is added and a sequencing joint is connected, and then the AMPureXP beads are used for fragment size selection. And finally, carrying out PCR amplification, and purifying the PCR product by using AMPure XP beads to obtain a final library. After the library is constructed, firstly using Qubit2.0 to carry out preliminary quantification, diluting the library to 1.5ng/ul, then using Agilent 2100 to detect the insert size of the library, and after the insert size meets the expectation, using a Q-PCR method to accurately quantify the effective concentration of the library (the effective concentration of the library is more than 2nM) so as to ensure the quality of the library. The schematic diagram of library construction is shown in FIG. 14.
(3) Sequencing on machine
And after the library is qualified, carrying out Illumina HiSeq sequencing on different libraries according to the effective concentration and the requirement of the target offline data volume.
(4) Analysis and Assembly of original sequences
And after the sequencing data is qualified, performing transcript splicing, assembling and analyzing. We obtained the Ceratoptera chinensis CYP18A1 gene.
Wax insect CYP18A1 analysis
1. Wax insect CYP18A1 gene and expression protein analysis
Through transcriptome analysis and screening, the obtained fraxinus chinensis CYP18A1 gene is 16997 bp long, the Codon Adaptation Index (CAI) is 0.698, the number of effective codons (ENC) is 52.698, and the GC content: 45.27%, GC3s content: 57.65%, has 1 Open Reading Frame (ORF), length 1608bp, stop codon TAA, codes 535 amino acids, and has the highest content of Leu (L) (58, 10.8%), and does not contain two amino acids of Pyl (O) and Sec (U); the instability factor was 45.84, greater than 40. The protein showed an amphipathic hydrophilic protein with a maximum hydrophobicity of 2.844 at amino acid position 23 and a minimum hydrophilicity of-2.744 between amino acids 152, with a peak distribution below 0 and a peak distribution above 0, and an average hydrophobicity of-0.204 (FIG. 1). The CYP18a1 protein is a double-transmembrane protein (fig. 2), located in the endoplasmic reticulum, functioning in concert with the endoplasmic reticulum (fig. 3), and contains a plurality of conserved domains, mainly belonging to the P450 superfamily family, located at amino acids 40-506 (fig. 4), which contains the most conserved hemoglobin binding domain, which contains an absolutely conserved cysteine residue, is the fifth coordinating ligand for hemoglobin iron, and contains the highly conserved P450 motif F-X-G-X-C-X-G, having a total of 73 phosphorylation sites (34 for Ser, 22 for Thr, and 17 for Tyr), and the activity and function of regulatory proteins may be regulated by phosphorylation reactions at these sites. The protein has a tertiary structure of monomers (monomer) formed by 253 alpha-helices, 26 Beta-turns, 55 extended chains and 201 random coils, and contains 1 BCD (Beta-Cyclodextrin) ligand, 1 HEM (PROTOPORPHYRIN IX CONTAINING FE) ligand, 1D 2V ((3S, 5Z, 7E, 22E) -9, 10-secoergosta-5, 7, 10, 22-tetraen-3-ol) ligand, and shorter extended peptide segments (EP) at the C and N ends (FIG. 5).
2. Ceratoptera chinensis CYP18A1 expression analysis result
By analyzing the PFKM values of CYP18a1, it was found that CYP18a1 was low expressed in first-instar male larvae (FM), first-instar female larvae (FF), early female adults (EA), late female adults (LA), and high expressed in second-instar male larvae (SM) and second-instar female larvae (SF) (fig. 6).
2.1 wax insect CYP18A1 exogenous vector construction and expression
(1) Primer design
Screening a CYP18A1 transcript sequence according to a fraxinus chinensis transcriptome database, analyzing the base sequence of the CYP18A1 gene through interference site prediction software (siDirect version 2.0), finding out a fragment with more interference sites, wherein the length of the fragment is 318bp, and the off-target effect is avoided. Primers were designed using Premier 6.0. Sal I and Sac I enzyme sites (SalI and SacI, underlined) were added to the upstream primer and the downstream primer of the synthesized CYP18A1 gene primer (Table 1).
TABLE 1
(2) Amplification of candidate Gene (FIG. 7)
The synthesized primer CYP18A1 (Table 1) was diluted to 10. mu.M for PCR amplification, and the specific reaction system (Table 2) and procedure for the amplification of the target gene were as follows:
TABLE 2
The PCR amplification procedure was: pre-denaturation at 94 ℃ for 5 min; denaturation at 94 ℃ for 30s, annealing at 60 ℃ for 30s, extension at 72 ℃ for 1min, and 30 cycles; extending for 10min at 72 ℃, and storing at 4 ℃.
(3) Gel recovery of PCR amplification products
After PCR, 1% agarose Gel electrophoresis is used for detecting CYP18A1 target gene fragments (adding an electrophoretogram), then a Gel block of a CYP18A1 gene band is cut off in an ultraviolet instrument, and a SanPrep Column type DNA Gel recovery Kit (SanPrep Column DNA Gel Extraction Kit) is used for recovery, wherein the experimental steps are as follows:
A. cutting off a gel block containing the CYP18A1 gene strip by using a sharp blade in an ultraviolet gel cutting instrument;
B. adding 5 times volume of Buffer B2, performing water bath for 10 minutes at 50 ℃, and performing manual mixing every few minutes in the process;
C. adding 1/3 volumes of isopropanol and mixing;
D. transferring into a centrifugal column, centrifuging at 8000 Xg/min for 30s, and discarding waste liquid;
E. adding 500 μ l of Wash Solution, centrifuging at 9000 Xg/min for 30s, and discarding the waste liquid;
F. repeating the step E1 times;
G. centrifuging the empty adsorption column at room temperature at 9000 Xg/min for 1 min;
H. transferring the adsorption column into a 1.5ml centrifuge tube, adding 30 mul of Elution Buffer, standing for 1 minute at room temperature, and centrifuging for 1 minute at 9000 Xg/min;
I. sucking the DNA solution in the centrifugal tube into the centrifugal column again for 9000 Xg for centrifugation for 1 minute; collecting a DNA solution;
J. the ultramicro spectrophotometer is used for measuring the concentration and purity of the target gene solution, and the target gene solution is stored in a refrigerator at the temperature of 20 ℃ below zero for later use.
(4) Enzyme digestion of target fragment and L4440 interference vector
The CYP18A1 rubber cutting obtained above is subjected to double digestion by Sac I and Sal I in an ice bath environment to recover a product and an L4440 plasmid vector.
A. The cleavage system is shown in Table 3:
TABLE 3
The mixture was gently flicked and the enzyme was allowed to act at 37 ℃ for 10 minutes.
B. Gel recovery of the cleavage products
After the enzyme digestion is finished, detecting double enzyme digestion products of CYP18A1 gene or L4440 plasmid by gel electrophoresis, then recovering the gel, measuring the concentration and purity of the recovered products, and storing at-20 ℃ for later use.
(5) T4 DNase ligation reaction
The T4 DNA ligase cuts the recovered CYP18A1 and L4440 plasmids, the experiment is carried out according to the reaction system shown in the table 4, and the overnight ligation is carried out, thus obtaining the recombinant plasmid exogenous vector CYP18A1+ L4440.
TABLE 4
Reagent | Amount of the composition used |
CYP18A1 target fragment | 9.5μl |
L4440 vector | 1.0μl |
T4 ligase Buffer | 2.0μl |
T4 ligase | 0.5μl |
dH2O | 7.0μl |
Total | 20.0μl |
(6) Transformation of recombinant plasmids
A. Transferring the exogenous vector CYP18A1+ L44405 ul into competent cell DH5 alpha (20 ul DH5 alpha), and keeping ice bath for 30 minutes;
B. after the ice bath is finished, quickly transferring the mixture into a water bath heat shock kettle with the constant temperature of 42 ℃ for 70 seconds;
C. it was quickly placed on ice and left to stand for 3 minutes;
D. add 400 μ l SOC liquid medium (with Amp +); wherein the SOC liquid culture medium (containing Amp +) comprises the following components: 34g/L SOC powder, 100mg/L Amp +, Trypton e 2% (w/v), Yeast extract 0.5% (w/v), NaCl 10mM, KCl 2.5mM, MgCl2 10mM,Glucose 20mM;
E.160r/min, shake fungus for 1h at 37 ℃;
F. coating part of the bacterial liquid on an SOC solid culture medium containing Amp +; wherein, the components of the SOC solid culture medium containing Amp + are 12g/L agar powder, 34g/L SOC powder, 100mg/L Amp +, Tryptone 2% (w/v), Yeast extract 0.5% (w/v), NaCl 10mM, KCl 2.5mM, MgCl2 10mM,Glucose 20mM。
G.37 ℃ for 14 hours.
(7) Screening and identification of expression vectors (FIG. 8)
A. Selecting SOC solid culture medium for cultureThe single bacterial beads of (2) were transferred to SOC liquid medium (containing Amp at 100. mu.g/ml)+) Culturing at 37 ℃ and 160r/min for 14h to obtain CYP18A1/L4440-HT115 bacterial liquid.
B. After PCR of the cultured bacterial liquid, electrophoresis is carried out for 30 minutes by using 1% agarose gel under the condition of 120V, a strip is detected,
C. the CYP18A1/L4440-HT115 bacterial liquid is subjected to amplification culture, plasmids are extracted, and the plasmids are sent to a company for sequencing, and the sequencing result is shown in figure 9.
Wax insect CYP18A1 gene target fragment expression and RNAi interference experiment
Inducible expression of dsRNA
The recombinant plasmid (CYP18A1-L4440) was transformed into HT115 competent strain, spread on SOC solid medium (containing 100. mu.g/ml ampicillin and 50. mu.g/ml tetracycline), cultured for 14h, picked single beads were transferred into SOC liquid medium (containing 100. mu.g/ml ampicillin and 50. mu.g/ml tetracycline), cultured at 37 ℃ on a shaker for 12h, and HT115 bacterial fluid containing the desired gene was selected (FIG. 10), and then the culture was added to 2XYT liquid medium containing 75. mu.g/ml ampicillin and 12.5. mu.g/ml tetracycline, cultured at 160r/min on a shaker at 37 ℃ until OD600And (3) when the concentration is 0.4-0.5, adding IPTG (concentration is 0.64mmol/L) for induction.
The SOC solid culture medium comprises 12g/L agar powder, 34g/L SOC powder, Tryptone 2% (w/v), Yeast extract 0.5% (w/v), NaCl 10mM, KCl 2.5mM, MgCl2 10mM,Glucose 20mM。
The SOC liquid culture medium comprises the following components: 34g/L SOC powder, Tryptone 2% (w/v), Yeast extract 0.5% (w/v), NaCl 10mM, KCl 2.5mM, MgCl2 10mM,Glucose 20mM;
The 2xYT liquid medium comprises the following components: 1.6% (W/V) Tryptone, 1% (W/V) Yeast extract, 0.5% (W/V) NaCl.
dsRNA transfection
The bacterial strain is diluted by DEPC water, CYP18A1/L4440-HT115 bacterial liquid with the concentration of 30ng/ml is prepared as an experimental group (CYP18A1), an empty plasmid L4440 is transferred into HT115 competent cells, and the L4440-HT115 is constructed as an experimental positive Control group (Control), and a negative Control group which is not treated is a natural group (CK). In the transfection period, the initial stage of the second-instar male nymphs of the fraxinus chinensis is selected, and because the initial stage of the second-instar male nymphs secretes a small amount of wax, the surface of the worm body is not coated with the fraxinus chinensis, and the bacterial liquid can directly act on the surface of the worm body and enter the body through the wax glands and pores on the surface of the fraxinus chinensis. The CYP18A1/L4440-HT115 bacterial liquid and the L4440-HT115 bacterial liquid are directly sprayed on the polypide by a spray bottle, the polypide is treated for 1 time at 9 o 'clock every morning and is continuously treated for 3 times, experimental samples are collected at intervals of 12h, 24h, 48h and 72h from the 9 o' clock on the third day, and the abundance in the CYP18A1 polypide is detected by qRT-PCR.
qRT-PCR (FIG. 11)
(1) Primer design
Gene-specific primers for qPCR were designed using Primer 6.0 (table 5).
TABLE 5
Diluting cDNA of all samples to 5 ng/mu l, diluting primers to 10 mu M, quantitatively detecting gene expression quantity by qRT-PCR, selecting beta-actin gene as internal reference, and performing 3 times of biological repetition on each sample.
(2) The reaction system is shown in Table 6:
TABLE 6
qPCR reaction: 95-30 s (pre-denaturation), 95-5 s (denaturation), 60-40 s (annealing), and 39 cycles of the second step.
The results show that the expression level of the target gene CYP18A1 is significantly lower than that of the control group 48 hours after the interference.
4. Detection of external morphology
By means of a body microscope VXH2000, changes of the body morphology and the growth condition of the wax worms were monitored by sampling every 10 days, changes of the external morphology (fig. 12), the metamorphosis development process and the projection area thereof were detected (13), and 5 heads were measured per experimental group.
The results show that, after the interference, the second-instar male nymphs of the wax beetles develop malformations and develop slowly.
The foregoing shows and describes the general principles, essential features, and advantages of the invention. It will be understood by those skilled in the art that the present invention is not limited to the embodiments described above, which are described in the specification and illustrated only to illustrate the principle of the present invention, but that various changes and modifications may be made therein without departing from the spirit and scope of the present invention, which fall within the scope of the invention as claimed. The scope of the invention is defined by the appended claims and equivalents thereof.
Sequence listing
<110> resource insect research institute of China forestry science research institute
Paralichthys olivaceus CYP18A1 gene and application thereof
<160> 3
<170> SIPOSequenceListing 1.0
<210> 1
<211> 1697
<212> DNA
<213> Artificial sequence ()
<400> 1
aaaaaaagaa aaaaaaaaga aaaatagaat gaatttttct tttttgaatg tgcatgtgcc 60
gaccttgatt aacaaaatgc cagaacatta gtgggaaccg actggcaacc ttttcgtgtt 120
caaaaaatcg ggtaacgatt cgtcagcgat tatttcacca tcgaatggtc tttcaatgag 180
ttgtatctta tagctggcgg gagttaaggt gatgccgaaa atgccttcta aatctggaag 240
tgattgacct tcgggcaatt taaggttgaa cgtgtgcaaa atcgaagaaa aaaataaaaa 300
tatttccatg cgagcgagaa attcacccaa acaatttcgt cgaccgacgc caaacggtat 360
aaaaaaatcg ggtttaacaa ctctgccttc ggaattgata aagcgacttg gacgaaattc 420
atccggtgac tcccacaatt ctggatcatt attgacagcg taaattaacg gaatgatttc 480
cgtatttttt ggtatggtaa atcctttgaa atttacgtct ttcatggtgg cgtgcgagtt 540
gcccaaaggt acgacactcg atttgcgcag cacctccaaa atggtcgcct ccgtgatggg 600
caaatagggt aaatcgtcaa aggtgggcaa ccgtttgcgg ccaacgacca tgtccagctc 660
agcctgaatt gaacgagcca gctccggata gtggaccatg tagatcaacg accagtgcaa 720
cgtggttttg gttgtctcca tgccggcggt gaacaggtcg acgacgattt ggcggatctg 780
cgagttgtgg tccttgccct ggaacagatt ttcgctgttt ccggacagct cggctcgccg 840
gatctccatc agatagcagt cgagcacgtc gcgcgtcttc gactcttcga acgtgcgtcg 900
atggtcgtcg atgatcttct ggaagaagtt gtgcgttttc gccttgttct cgtcgatttt 960
cttcatctcc ttcaggaagt agggaaagtg gcgcagaaac gggaaatagt tgaggaagac 1020
gatgccgcca aacagctgga agccttcttc gattttctcc atcagtcgcc ggaaaatggg 1080
atcgttgaag ctgaagcgga cgctcatcag cagcgagcag atgacgttgc tcaccgagat 1140
gaccagactg tggttcaaat cgatggcgcg tcctttttga cttttcaaat tgtccagcaa 1200
gtaggaaacc tcgcccataa ttctgctctc cagatgattg ttgtttttct tattaaagat 1260
ggtcattcca aagcaacgta aacacgaatg cacaaatcga cgttgctctt tccatatatt 1320
tccttgcgtg tttataattc catagccacc gagtaatttg taaaattcat tcgacggttt 1380
accactgaat tcttctttat tgaacgcctc cttaatccac ttcggatcgc tcaatatgat 1440
cacatttttc aagcccaaat tcaccgaaaa tattttacca tatttctgcg acaaagccaa 1500
atattgacga tgaacgtttt gacctttgga aatgaaatat aggaaaccga tgactggcag 1560
accccaaggt ccgggaggca tatttctgta ttttctgtac ttcattagca tgtacagaca 1620
taagatggtg cctatcagca gacgtgtgtc gcagctattc caaaatcgtc caaatttcat 1680
ttttgtatag tcgaaca 1697
<210> 2
<211> 535
<212> PRT
<213> Artificial sequence ()
<400> 2
Phe Asp Tyr Thr Lys Met Lys Phe Gly Arg Phe Trp Asn Ser Cys Asp
1 5 10 15
Thr Arg Leu Leu Ile Gly Thr Ile Leu Cys Leu Tyr Met Leu Met Lys
20 25 30
Tyr Arg Lys Tyr Arg Asn Met Pro Pro Gly Pro Trp Gly Leu Pro Val
35 40 45
Ile Gly Phe Leu Tyr Phe Ile Ser Lys Gly Gln Asn Val His Arg Gln
50 55 60
Tyr Leu Ala Leu Ser Gln Lys Tyr Gly Lys Ile Phe Ser Val Asn Leu
65 70 75 80
Gly Leu Lys Asn Val Ile Ile Leu Ser Asp Pro Lys Trp Ile Lys Glu
85 90 95
Ala Phe Asn Lys Glu Glu Phe Ser Gly Lys Pro Ser Asn Glu Phe Tyr
100 105 110
Lys Leu Leu Gly Gly Tyr Gly Ile Ile Asn Thr Gln Gly Asn Ile Trp
115 120 125
Lys Glu Gln Arg Arg Phe Val His Ser Cys Leu Arg Cys Phe Gly Met
130 135 140
Thr Ile Phe Asn Lys Lys Asn Asn Asn His Leu Glu Ser Arg Ile Met
145 150 155 160
Gly Glu Val Ser Tyr Leu Leu Asp Asn Leu Lys Ser Gln Lys Gly Arg
165 170 175
Ala Ile Asp Leu Asn His Ser Leu Val Ile Ser Val Ser Asn Val Ile
180 185 190
Cys Ser Leu Leu Met Ser Val Arg Phe Ser Phe Asn Asp Pro Ile Phe
195 200 205
Arg Arg Leu Met Glu Lys Ile Glu Glu Gly Phe Gln Leu Phe Gly Gly
210 215 220
Ile Val Phe Leu Asn Tyr Phe Pro Phe Leu Arg His Phe Pro Tyr Phe
225 230 235 240
Leu Lys Glu Met Lys Lys Ile Asp Glu Asn Lys Ala Lys Thr His Asn
245 250 255
Phe Phe Gln Lys Ile Ile Asp Asp His Arg Arg Thr Phe Glu Glu Ser
260 265 270
Lys Thr Arg Asp Val Leu Asp Cys Tyr Leu Met Glu Ile Arg Arg Ala
275 280 285
Glu Leu Ser Gly Asn Ser Glu Asn Leu Phe Gln Gly Lys Asp His Asn
290 295 300
Ser Gln Ile Arg Gln Ile Val Val Asp Leu Phe Thr Ala Gly Met Glu
305 310 315 320
Thr Thr Lys Thr Thr Leu His Trp Ser Leu Ile Tyr Met Val His Tyr
325 330 335
Pro Glu Leu Ala Arg Ser Ile Gln Ala Glu Leu Asp Met Val Val Gly
340 345 350
Arg Lys Arg Leu Pro Thr Phe Asp Asp Leu Pro Tyr Leu Pro Ile Thr
355 360 365
Glu Ala Thr Ile Leu Glu Val Leu Arg Lys Ser Ser Val Val Pro Leu
370 375 380
Gly Asn Ser His Ala Thr Met Lys Asp Val Asn Phe Lys Gly Phe Thr
385 390 395 400
Ile Pro Lys Asn Thr Glu Ile Ile Pro Leu Ile Tyr Ala Val Asn Asn
405 410 415
Asp Pro Glu Leu Trp Glu Ser Pro Asp Glu Phe Arg Pro Ser Arg Phe
420 425 430
Ile Asn Ser Glu Gly Arg Val Val Lys Pro Asp Phe Phe Ile Pro Phe
435 440 445
Gly Val Gly Arg Arg Asn Cys Leu Gly Glu Phe Leu Ala Arg Met Glu
450 455 460
Ile Phe Leu Phe Phe Ser Ser Ile Leu His Thr Phe Asn Leu Lys Leu
465 470 475 480
Pro Glu Gly Gln Ser Leu Pro Asp Leu Glu Gly Ile Phe Gly Ile Thr
485 490 495
Leu Thr Pro Ala Ser Tyr Lys Ile Gln Leu Ile Glu Arg Pro Phe Asp
500 505 510
Gly Glu Ile Ile Ala Asp Glu Ser Leu Pro Asp Phe Leu Asn Thr Lys
515 520 525
Arg Leu Pro Val Gly Ser His
530 535
<210> 3
<211> 318
<212> DNA
<213> Artificial sequence ()
<400> 3
tcatcagcag cgagcagatg acgttgctca ccgagatgac cagactgtgg ttcaaatcga 60
tggcgcgtcc tttttgactt ttcaaattgt ccagcaagta ggaaacctcg cccataattc 120
tgctctccag atgattgttg tttttcttat taaagatggt cattccaaag caacgtaaac 180
acgaatgcac aaatcgacgt tgctctttcc atatatttcc ttgcgtgttt ataattccat 240
agccaccgag taatttgtaa aattcattcg acggtttacc actgaattct tctttattga 300
Claims (8)
1. The fraxinus chinensis CYP18A1 gene is characterized in that the nucleotide sequence of the fraxinus chinensis CYP18A1 gene is shown in SEQ ID NO. 1.
2. The fraxinus chinensis CYP18a1 gene-encoding protein of claim 1, wherein the amino acid sequence of the encoding protein is represented by SEQ ID No. 2.
3. An expression vector, an expression cassette, a transgenic cell line or a recombinant bacterium containing the fraxinus chinensis CYP18a1 gene of claim 1.
4. The recombinant vector containing the target gene in the fraxinus chinensis CYP18a1 gene of claim 1, wherein the nucleotide sequence of the target gene is shown in SEQ ID No. 3.
5. The wax insect CYP18A1 gene of claim 1, for regulating the growth and development speed of wax insect.
6. The wax insect CYP18A1 gene of claim 1, for prolonging wax secretion time of wax insect.
7. The use of the wax insect CYP18A1 gene of claim 1 for breeding improved varieties of wax insect.
8. The use of the fraxinus chinensis CYP18a1 gene of claim 1 to increase production of fraxinus chinensis.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010821539.9A CN111944831A (en) | 2020-08-15 | 2020-08-15 | Ceratopteris chinensis CYP18A1 gene and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010821539.9A CN111944831A (en) | 2020-08-15 | 2020-08-15 | Ceratopteris chinensis CYP18A1 gene and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111944831A true CN111944831A (en) | 2020-11-17 |
Family
ID=73342744
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010821539.9A Withdrawn CN111944831A (en) | 2020-08-15 | 2020-08-15 | Ceratopteris chinensis CYP18A1 gene and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111944831A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109112117A (en) * | 2017-09-04 | 2019-01-01 | 华中农业大学 | A kind of isolated striped rice borer CYP15C1 gene and its coding albumen |
-
2020
- 2020-08-15 CN CN202010821539.9A patent/CN111944831A/en not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109112117A (en) * | 2017-09-04 | 2019-01-01 | 华中农业大学 | A kind of isolated striped rice borer CYP15C1 gene and its coding albumen |
Non-Patent Citations (1)
Title |
---|
LIU PENGFEI ET AL.: "Regulation of Hormone-Related Genes in Ericerus pela (Hemiptera: Coccidae) for Dimorphic Metamorphosis" * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108610427B (en) | Migratory locust diapause hormone gene and application thereof in regulation and control of insect diapause | |
CN109734798B (en) | Migratory locust serine protease inhibitor 7, and coding gene and application thereof | |
WO2006017960A1 (en) | A detoxifizyme having activity of transforming aflatoxin and the gene encodes thereof | |
CN108546694B (en) | Asian locusta protein tyrosine phosphatase PTPN4 and coding gene and application thereof | |
CN109207634B (en) | Fluorescent quantitative reference gene under drought stress of Changsha dichroa and special primer and application thereof | |
CN111763252B (en) | Bemisia tabaci MED cryptomorphic chromatin remodeling factor Btbrm2 and coding gene and application thereof | |
CN106831972B (en) | Full-length sequence of mudskipper pleomorphic vitellogenin Vtg gene and cloning method thereof | |
CN111944831A (en) | Ceratopteris chinensis CYP18A1 gene and application thereof | |
WO2008154650A2 (en) | Drought responsive genes in plants and methods of their use | |
CN110106175B (en) | dsRNA (double-stranded ribonucleic acid) and application thereof in pest control | |
CN109913480B (en) | Locust uridine diphosphate glucuronosyltransferase gene and application thereof | |
JP2009254234A (en) | Gene that regulates color of shell of pearl oyster and pearl and protein encoded by the same | |
CN110129327B (en) | Migratory locust pore canal formation related geneLmsnarAnd application of dsRNA thereof in locusta migratoria control | |
CN109810993B (en) | Locust beta-D-glucoside hydrolase gene and application thereof | |
JP2009523413A (en) | Promoter sequence | |
CN108610426B (en) | Migratory locust rhythm genes clk, cyc and per and application thereof in regulation and control of diapause of insects | |
CN109182549B (en) | Primer and method for detecting transcription level of agasicles hygrophila OR gene | |
JP2007236356A (en) | Structural gene of seashell of pearl oyster or pearl | |
CN109735531B (en) | Zero background cloning method of high GC content gene and application thereof | |
CN114395572B (en) | Freshwater shrimp legumain-like gene and application of dsRNA thereof | |
CN109161602B (en) | Primer and method for detecting transcription level of JHE gene of agasicles hygrophila | |
CN114990133B (en) | Tobacco carotenoid metabolism related gene and application | |
CN113817752B (en) | Application of slr0681 gene in synthesis of synechocystis carotene | |
KR101155994B1 (en) | Protein and its Gene of laver, giving High-Temperature-Resistance | |
CN108752444B (en) | Chlorophytum comosum root nitrate transport protein CcNPF8.3.2 and coding gene and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20201117 |
|
WW01 | Invention patent application withdrawn after publication |